Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on April 24, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Drug Procurement (Test Article Supply)

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424690
New
SLED
Chemical Products Qualified Vendor List - Additional Vendors
Solicitation # STATE 0000000547SL
The State of Missouri, through the Office of Administration Division of Purchasing, is soliciting additional qualified vendors to be added to a Qualified Vendor List for chemical products. These supplies support the Missouri Department of Corrections, Missouri Vocational Enterprises at the Eastern Reception and Diagnostic Correctional Center Chemical Factory in Bonne Terre, Missouri. The contract period runs from the date of award through March 9, 2027. Because of market volatility, the state will not request pricing during the initial solicitation; instead, it will request written quotes from awarded vendors on an as-needed basis and award individual purchases to the lowest and best vendor at the time of the request. Deliveries must be made FOB Destination, Freight Prepaid and Allowed, with a desired delivery window of ten calendar days following a properly executed order. Vendors must comply with strict safety and hazard communication standards, including providing warning labels and Safety Data Sheets that adhere to OSHA’s Hazard Communication Standard. The evaluation process includes bonus points for Missouri service-disabled veteran business enterprises and organizations for the blind or sheltered workshops. Additionally, vendors must certify compliance with the Domestic Products Procurement Act and provide certifications regarding the Anti-Discrimination Against Israel Act. Payments are processed within 30 calendar days of receiving a valid invoice via the MissouriBUYS system.
PROC OA DIVISION OF PURCHASING PROCUREMENTS

POSTED

about 22 hours ago

DEADLINE

in 7 days

AI Contract Overview

Show more

The contract pertains to the procurement and supply of a marketed small molecule drug for use in FDA-sponsored neuropharmacology research studies. The drug, referred to as the test article, is intended solely for experimental purposes and must meet all regulatory and quality standards required for controlled scientific investigations. The procurement is structured as a subcontract under the Department of Health and Human Services through the FDA Office of Acquisition and Grant Services, with the NAICS code 424690 indicative of pharmaceutical and biological product merchant wholesalers. The solicitation was posted on April 24, 2026, with a firm deadline for responses set for May 4, 2026, at 6:00 PM, requiring timely submission of proposals that detail sourcing capabilities, compliance with FDA guidelines, and logistical readiness for delivery. The place of performance and point of contact details are not specified, but the drug must be supplied in quantities and formulations suitable for validated neuropharmacological experimentation. All parties are expected to adhere to federal acquisition regulations and ensure the integrity, traceability, and appropriate handling of the substance throughout the supply chain.

General Info

Procurement of FDA-compliant small molecule drug for neuropharmacology research under HHS subcontract by May 4, 2026.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

424690 - Other Chemical and Allied Products Merchant WholesalersView NAICS

Place of Performance

MD, USA

Set-Aside

NONE

Documents

This scope was carved out of NCTR-2026-134171.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

CNS Organoid Neuropharmacological Analysis

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Purchase and supply of a marketed small molecule drug (test article) for experimental use in FDA neuropharmacology studies.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS